Cardioprotective Effects of Nanoemulsions Loaded with Anti-Inflammatory Nutraceuticals against Doxorubicin-Induced Cardiotoxicity
Vincenzo Quagliariello(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Nicola Maurea(Cancer Institute (WIA)), Giovanna Piscopo(University of Cagliari), Paolo A. Netti(University of Naples Federico II), Viviana Narciso(University of Naples Federico II), Raffaele Vecchione(Italian Institute of Technology), Carmen Formisano(Federico II University Hospital), Carmela Coppola, Chiara Di Cicco(Italian Institute of Technology), Orazio Taglialatela‐Scafati(University of Naples Federico II), Rosario Vincenzo Iaffaioli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Rolando Paciello(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), A Capua(Italian Institute of Technology), Gerardo Botti(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 89
Related Papers
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Recent advances in holographic 3D particle tracking
|Advances in Optics and Photonics|2015|312
Basic principles of biobanking: from biological samples to precision medicine for patients
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2021|223